This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Genentech, Inc., Khn Solutions, Inc., Roche Palo Alto LLC. Active years: 2003-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2003-2025
Title: The Innovative Contributions of David Shaw
Introduction
David Shaw is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, holding a total of five patents. His work focuses on advanced methodologies in gene editing and image characterization, showcasing his expertise and innovative spirit.
Latest Patents
One of David Shaw's latest patents is titled "Efficient TCR gene editing in T lymphocytes." This patent relates to engineered T cells and methods for their creation and application, as well as the reagents necessary for producing these engineered T cells. Another notable patent is "Cell line development image characterization with convolutional neural networks." This method involves a computing system that processes images to identify and verify cell clusters, utilizing deep-learning models to ensure accurate characterization of cell morphology.
Career Highlights
Throughout his career, David Shaw has worked with leading companies in the biotechnology sector, including Genentech, Inc. and Khn Solutions, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
David has collaborated with notable professionals in his field, including Keith Harry Nothacker and James Michael Bradshaw. These partnerships have further enhanced his research and development efforts, leading to impactful innovations.
Conclusion
David Shaw's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to influence advancements in gene editing and image analysis, making a lasting impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile